C12N 2710/24062
By genetic engineering
Official title: by genetic engineering
C12N2710/24062 (By genetic engineering) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 7
- Assignees
- 4
- Inventors
- 15
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for inducing an enhanced immune response using poxvirus vectors2 Jun 2026US 12,644,125 B2Bavarian Nordic A/S
- Myxoma virus mutants for cancer treatment29 May 2018US 9,980,994 B2Robarts Research Institute
- Myxoma virus mutants for cancer treatment20 Aug 2013US 8,512,713 B2Robarts Research Institute
- Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses23 Nov 1999US 5,989,561 AVirogenetics Corporation
- Oncolytic viruses that express multi-specific immune cell engagers21 Mar 2024US 2024/0093158 A1Arizona Board of Regents on behalf of Arizona State University
- Compositions and Methods for Inducing an Enhanced Immune Response Using Poxvirus Vectors15 Oct 2020US 2020/0325477 A1Bavarian Nordic A/S
- Compositions and methods for inducing an enhanced immune response using poxvirus vectors29 Dec 2016US 2016/0376596 A1Bavarian Nordic A/S
- Myxoma virus mutants for cancer treatment19 May 2016US 2016/0136212 A1Robarts Research Institute
- Myxoma virus mutants for cancer treatment19 Dec 2013US 2013/0336930 A1Robarts Research Institute
Most cited
By later US patents